# Qunomedical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/qunomedical

- Industry: Healthcare IT
- Headquarters: Berlin, Germany
- Website: www.qunomedical.com
- Total disclosed funding: $12M
- Latest round: Series A (Nov 9, 2022)
- Investors on record: 10

## About

Based in Germany, Qunomedical GmbH specializes in connecting patients with high-quality medical treatments through a comprehensive online platform, ensuring access to vetted healthcare professionals globally.Founded in 2015 in Berlin, Germany, Qunomedical GmbH operates as a digital health platform that connects patients with healthcare providers globally. The company has undergone no significant pivots or changes in its core mission and has no known subsidiaries. Sophie Chung, the founder, has a background in healthcare entrepreneurship. Qunomedical has successfully raised EUR 10.00 mn in Series A funding on November 9, 2022, led by Bertelsmann Capital Ventures, with returning investors participating. This funding round marks the total amount raised to EUR 10.00 mn and the current company valuation at EUR 14.93 mn.Qunomedical specializes in providing high-quality medical treatments both domestically and internationally, focusing on a patient-centric approach. Their core offerings include a robust online platform that connects patients with vetted medical professionals across various specialties, including hair transplants, dentistry, rhinoplasty, in vitro fertilization, and more. The company employs a dedicated medical board to ensure that all doctors listed meet stringent quality criteria, thereby enhancing patient trust and safety. Additionally, Qunomedical offers comprehensive support services, such as personalized patient managers and a 24/7 support system, to facilitate seamless medical journeys for clients. The services are marketed to a global clientele, including patients seeking affordable healthcare alternatives in countries such as Turkey, Germany, and Cyprus.Qunomedical's revenue model is primarily built on facilitating transactions between patients and healthcare providers. The company operates through a direct-to-consumer approach, with patients utilizing the platform for a range of medical services. Revenue is generated through service fees associated with bookings made through the platform, as well as potential partnerships with healthcare providers. Pricing for treatments varies significantly, with flagship services such as FUE hair transplants starting from EUR 1,850 and in vitro fertilization services beginning at EUR 2,800. These fixed pricing structures contribute to the transparency and affordability that Qunomedical promotes, positioning them effectively within the medical tourism sector.In November 2022, Qunomedical GmbH raised EUR 10.00 mn in Series A funding, which will be utilized to scale its new B2B product Qunosuite within the healthcare sector and accelerate its product development. The company aims to expand its reach by entering new international markets, specifically targeting additional European regions by 2024, alongside enhancing its existing service offerings. This funding will support these strategic initiatives to improve and broaden their medical service platform.

## Funding rounds

- Series A, Nov 9, 2022, $10M — Bertelsmann Capital Ventures, Dieter von Holtzbrinck Ventures, Calm/Storm Ventures, MS&AD Ventures, Nebrül GmbH & Co. KG, Merlin Gmbh, Schnickmann Verwaltungs GmbH
- Series A, Jun 1, 2021 — Calm/Storm Ventures, MS&AD Ventures
- Seed, Aug 15, 2017, $2M — 500 Global, Kima Ventures, Project A
- Seed, Apr 7, 2016 — Project A

## Investors

- Project A (https://capitalatlas.ai/funds/project-a) — Seed
- 500 Global (https://capitalatlas.ai/funds/500-global) — Seed
- Kima Ventures (https://capitalatlas.ai/funds/kima-ventures) — Seed
- Calm/Storm Ventures (https://capitalatlas.ai/funds/calm-storm-ventures) — Series A
- MS&AD Ventures (https://capitalatlas.ai/funds/ms-ad-ventures) — Series A
- Bertelsmann Capital Ventures — Series A
- Dieter von Holtzbrinck Ventures (https://capitalatlas.ai/funds/dieter-von-holtzbrinck-ventures) — Series A
- Nebrül GmbH & Co. KG — Series A
- Merlin Gmbh — Series A
- Schnickmann Verwaltungs GmbH — Series A